By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today said fourth quarter revenues for its Life Sciences & Diagnostics division rose to $681.9 million from $432.1 million a year ago.

The Washington-based conglomerate began reporting Life Sciences & Diagnostics as a separate segment this quarter. Reporting those businesses in the year-ago period also as its own segment, revenues for the three months ended Dec. 31, 2010 represented a 58 percent spike year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.